RIPK1 and Yersinia infectious disease: It further implies that during episodes of infection, in people with TBK1 mutations, the NLRP3 pathway may be hyperactivated in macrophages, following either direct activation, as we have observed with Listeria, or downstream of RIPK1, as seen following Yersinia infection, and thus will greatly contribute to immunopathology.